In vivo, silencing TMPO-AS1 reduced tumor volume (Figure 3(a)) and tumor weight (Figure 3(b)), suggesting that silencing TMPO-AS1 inhibits tumor growth in vivo. The gene discussed is TMPO; the disease is neoplasm.